Earth Science Tech, Inc. SEC filings ETST

Earth Science Tech, Inc. has 404 filings in SEC EDGAR's recent list, going back to Feb 1, 2012. Its latest annual report, Form 10-K, was filed on Jun 18, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (officer or director change). The company's fiscal year ends on March 31.

Earth Science Tech, Inc. SEC filings
Form Description Filed Period
10-K Annual report Jun 18, 2026 Mar 31, 2026
10-K Annual report Jun 27, 2025 Mar 31, 2025
10-K Annual report Jun 28, 2024 Mar 31, 2024
10-K/A Amended annual report Feb 27, 2024 Mar 31, 2023
10-K Annual report Jun 20, 2023 Mar 31, 2023
10-K/A Amended annual report Jul 22, 2022 Mar 31, 2022
10-K Annual report Jul 15, 2022 Mar 31, 2022
10-K/A Amended annual report Feb 22, 2022 Mar 31, 2021
10-K Annual report Sep 28, 2021 Mar 31, 2021
10-K/A Amended annual report Aug 18, 2020 Mar 31, 2020
10-K Annual report Aug 10, 2020 Mar 31, 2020
10-K/A Amended annual report Jul 22, 2019 Mar 31, 2019
10-K/A Amended annual report Jul 8, 2019 Mar 31, 2019
10-K Annual report Jul 1, 2019 Mar 31, 2019
10-K/A Amended annual report May 10, 2016 Mar 31, 2015
10-K Annual report Aug 5, 2015 Mar 31, 2015
10-K/A Amended annual report Jul 16, 2014 Mar 31, 2014
10-K Annual report Jul 16, 2014 Mar 31, 2014
10-K Annual report May 10, 2013 Mar 31, 2013

Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ETST (OTC)
Fiscal year ends
March 31
Incorporated in
FL
Headquarters
Miami, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1538495
Former names
Ultimate Novelty Sports Inc. (until Apr 17, 2014)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.